HH
ACAD icon

HWG Holdings’s Acadia Pharmaceuticals ACAD Stock Holding History

HWG Holdings’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-30,400
Closed -$492K – 101
2018
Q4 		$492K Sell
30,400
-1,100
-3% -$21.4K 1.04% 15
2018
Q3 		$654K Hold
31,500
– – 0.44% 43
2018
Q2 		$481K Hold
31,500
– – 0.4% 48
2018
Q1 		$708K Sell
31,500
-1,500
-5% -$41.5K 0.66% 34
2017
Q4 		$994K Hold
33,000
– – 0.84% 30
2017
Q3 		$1.24M Buy
33,000
+6,600
+25% +$215K 0.98% 30
2017
Q2 		$736K Buy
+26,400
New +$787K 0.54% 23

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

HWG Holdings's ACAD Position: Q1 2018 in Review

HWG Holdings sold out of Acadia Pharmaceuticals (ACAD) in Q1 2018, closing a stake of 460 shares — an estimated $12.7K sold.

HWG Holdings first reported a position in ACAD in Q4 2013 and held it in 14 quarters. The position peaked at $16M in Q4 2013. 196 funds tracked by Wall St. Rank hold ACAD as of Q1 2018.

  • HWG Holdings reported no remaining Acadia Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • HWG Holdings sold 460 Acadia Pharmaceuticals shares in Q1 2018, an estimated $12.7K.
  • HWG Holdings first reported a position in Acadia Pharmaceuticals in Q4 2013 and held it in 14 quarters.
  • HWG Holdings's Acadia Pharmaceuticals position peaked at $16M in Q4 2013.
  • 196 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2018.

Based on HWG Holdings's 13F filing for Q1 2018, filed 27 Apr 2018.